⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 26, 2025Open Access

Acute Viral-Induced Myopathy Following COVID-19: A Case Report

Ragda A. Kahiyah Aymen Alkarawi

View Full Paper

Ask AI

Bookmark

Share

Key Points

Elevated levels of lactate dehydrogenase and alanine aminotransferase indicate tissue damage related to myopathy.
Neurological examination ruled out conditions like Guillain–Barré syndrome, pointing to a distinct myopathy.
The patient presented with multiple symptoms, including myalgia and fatigue, following COVID-19, demonstrating the diverse impact of the virus.
Recognition of respiratory symptoms alongside myopathy is crucial for appropriate diagnosis and management.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Case report highlights acute myopathy development in a patient post COVID-19, suggesting immune dysregulation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kahiyah et al. (2025) studied this question.

synapsesocial.com/papers/68da58e0c1728099cfd11639 https://doi.org/10.20944/preprints202509.2226.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Acute viral-induced myopathy following COVID-192025
2A Case of COVID-19-Triggered Polymyositis Leading to Rhabdomyolysis2024
3A Case Report and Literature Review of New-Onset Myasthenia Gravis after COVID-19 Infection2024
4Electrophysiological features and outcomes of post-infectious myoclonus-ataxia syndrome: a case report and literature reviewCase Report · 2026
5The impact that myocarditis for post-acute COVID-19 syndrome may be dermatomyositis-like myocarditis: A case reportcase_report · 2023 · 4 citations